Featured Posts
Blog
New Inflation Numbers Show Folly of Price Controls
Today’s release of inflation numbers by the Bureau of Labor Statistics confirms that the loudest voices in favor of price controls are usually the…
National Review
Innovators to the Rescue
Thirty years ago, I spoke at a conference on xenotransplantation — the transplantation of organs, cells, or tissues between species — at Columbia…
Blog
Democrats’ Drug Price Control Bill Is a Prescription for Disaster
Last Thursday, House Democrats reintroduced a bill from the last Congress, which they claim will protect Medicare from excessive prescription drug prices. Sadly, it…
Search Posts
Blog
Growing Human Organs for Fun and Profit
Our friends at Freethink Media have an excellent new video out about medical innovation—in this case, how a new company is developing…
The Washington Examiner
Trump Keeps His Promise, Dying Patients Get a Second Chance At Life
The Washington Examiner cited the Competitive Enterprise Institute on the direct toll to human life that regulations impose as a result of ever-increasing FDA clinical…
The Hill
‘Right to Try’ Is a Win for Patient Rights and President Trump
The Hill cited the Competitive Enterprise Institute on the overwhelming cost of compliance which taxes the American economy and in this case limits pharmaceutical ingenuity…
Blog
Congress Could Give Desperate Patients ‘Right to Try’ Experimental Medications
The House of Representatives will soon vote on a companion bill to S. 204, the Right to Try Act. This bill would prevent the…
U.S. News & World Report
Don’t Blunt the Marijuana Revolution
U.S. News & World Report covers the coalition letter, led by CEI, advocating for the Rohrabacher medical marijuana amendment. America is undergoing a somewhat…
Blog
Ohio Drug Price Initiative Gives Taxpayer Money to Unnecessary Lawyers
Lawyers and allied interest groups have long enriched themselves at taxpayers’ expense. But usually, it has been by bringing lawsuits, not defending them.